These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Manganese-enhanced magnetic resonance imaging (MEMRI) of brain activity and applications to early detection of brain ischemia. Aoki I; Naruse S; Tanaka C NMR Biomed; 2004 Dec; 17(8):569-80. PubMed ID: 15617055 [TBL] [Abstract][Full Text] [Related]
14. Contrast agents in dynamic contrast-enhanced magnetic resonance imaging. Yan Y; Sun X; Shen B Oncotarget; 2017 Jun; 8(26):43491-43505. PubMed ID: 28415647 [TBL] [Abstract][Full Text] [Related]
15. Nanotechnology and MRI contrast enhancement. Matson ML; Wilson LJ Future Med Chem; 2010 Mar; 2(3):491-502. PubMed ID: 21426177 [TBL] [Abstract][Full Text] [Related]
16. Ensemble of expert deep neural networks for spatio-temporal denoising of contrast-enhanced MRI sequences. Benou A; Veksler R; Friedman A; Riklin Raviv T Med Image Anal; 2017 Dec; 42():145-159. PubMed ID: 28802145 [TBL] [Abstract][Full Text] [Related]
17. Heading toward Macromolecular and Nanosized Bioresponsive MRI Probes for Successful Functional Imaging. Angelovski G Acc Chem Res; 2017 Sep; 50(9):2215-2224. PubMed ID: 28841293 [TBL] [Abstract][Full Text] [Related]
18. Comparison of contrast agents with high molarity and with weak protein binding in cerebral perfusion imaging at 3 T. Thilmann O; Larsson EM; Björkman-Burtscher IM; Ståhlberg F; Wirestam R J Magn Reson Imaging; 2005 Nov; 22(5):597-604. PubMed ID: 16200539 [TBL] [Abstract][Full Text] [Related]
19. Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Cavagna FM; Maggioni F; Castelli PM; Daprà M; Imperatori LG; Lorusso V; Jenkins BG Invest Radiol; 1997 Dec; 32(12):780-96. PubMed ID: 9406019 [TBL] [Abstract][Full Text] [Related]